Investor Relations :: One World Pharma, Inc. (OWPC)

Latest News

Hemp Inc. Signs Letter of Intent to Purchase CBD Ingredients from One World Pharma, SAS in Colombia

Feb 10, 2020

View Press Release

One World Pharma Receives Multi-Year Purchase Order for $1.7 Million in Hemp Seeds

Jan 30, 2020

One World Pharma Receives the Highest Civilian Honor for its Humanitarian Activities in Colombia

Jan 16, 2020

View All News

Company Presentation

View Presentation

LD Micro 12th Annual Main Event

View All

Q3 2019

Quarter Ended Sep 30, 2019

10-Q

PDF HTML

XBRL

ZIP XLS HTML

Latest Annual Filing

For Year Ending December 31, 2018

View Filing

Company Overview

One World Pharma Inc. is the U.S. parent company of One World Pharma SAS, a licensed cannabis and hemp producer with offices and operations in Bogota and Popayan, Colombia. One World Pharma planted its first crop of cannabis in 2018 at its cultivation site in Popayan, Colombia, which it expects to begin harvesting in the first quarter of 2019. The Company intends to supply the highest quality cannabis and hemp derivatives in crude oil, distillate and isolate forms for industrial scale production to serve global cannabis demand. Its products will be produced and tested to GMP and ISO standards.

View Management Team View Board of Directors

Investor Contact Information

Company

One World Pharma, Inc.
3471 West Oquendo Road
Suite 301
Las Vegas, NV 89118

Investor Relations

Integrity Media Inc.
T: (888) 216-3595
info@integrityir.com
www.IntegrityIR.com

© 2020 Copyright. All rights are reserved by One World Pharma Inc.

Terms & Conditions

Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.